帕博利珠单抗治疗复发或难治性胸腺上皮肿瘤:评NCT02607631研究

    Pembrolizumab for the Treatment of Refractory or Relapsed Thymic Epithelial Tumors: Review of the NCT02607631 Study

    /

    返回文章
    返回